July 24, 2012
Vancouver, BC – Dr. Alan Winter, President and CEO of Genome British Columbia is pleased to announce the appointment of Dr. John Shepherd to its Board of Directors. Dr. Shepherd is currently the director of the Leukemia/Bone Marrow Transplant Program (BMT) of BC and a Clinical Professor of Medicine at the University of British Columbia.
Dr. Shepherd completed undergraduate studies at UBC and then went on to obtain a Masters degree in Medical Sciences at the University of Calgary. Following this, he completed medical school at the University of Calgary in 1981 and did his medical residency at the University of Toronto. He returned to Vancouver in 1984 and completed his fellowship in Hematology at UBC followed by a term as a Leukemia/BMT fellow with the Leukemia/BMT Program of BC, a joint program of the BCCA, Vancouver General Hospital, and the University of BC.
He has been on staff with the Program since 1987 and his clinical research has spanned the therapy of elderly patients with acute myeloid leukemia, advances in multiple myeloma, and novel therapy of chronic myeloid leukemia. He has authored or co-authored over 300 publications, abstracts and reviews and has taught at UBC in hematology and general internal medicine.
From 2001-2007 he served in progressive medical administration positions with the Vancouver Coastal Health Authority, most recently as Vice President, Clinical Quality, Safety, and Health Service Networks while continuing his clinical role. In 2007 he returned to full time clinical academic practice and in July 2010 he became the director of the Leukemia/BMT Program of BC.
“We are honoured that such an experienced and remarkable individual in BC’s medical and life sciences community has agreed to join us,” says Dr. Winter.
More info at: www.genomebc.ca/profile/people/board-of-directors
